drugset / Trial / NCT05908825

Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults

NCT05908825 ↗

RandomizedSequentialDouble-blindTreatment

Summary

This is a split-face, double-blind, placebo-controlled study assessing the use of a novel exfoliative serum with a chemical peel to improve photodamage in healthy female subjects between the ages of 30 and 65 years, inclusive, with Fitzpatrick skin types I-VI.

Timeline

Start
2023-06-22
Primary completion
2023-11-16
Completion
2024-01-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin C with AHA Exfoliative Serum Unknown — Topical

Indications

No indication recorded.